Price
No data yet.
Social Signal Score
Analyst Ratings
1 analystRevenue
$1.49B+2.24%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Nicola Loporcaro
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 34,000
- Beta
- 0.03
- Country
- US
Financials
GMRS has only 2 quarterly periods on file — the charts below show the full history available.
Revenue
$1.49B+2.2%Net Income
$-28.28M-126.6%EBITDA
$146.57M-51.3%Free Cash Flow
$0.00-100.0%EPS (diluted)
$-0.52-126.4%Shares Outstanding (diluted)
54.02M-0.0%Operating Expenses
$282.78MCash & Debt
$496.76MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $5.74B | $206.23M | $0.16 |
Valuation
Project earnings forward and see what return today's price implies.
Not enough reported EPS history to estimate growth — this is a placeholder, not an estimate.
- EPS in 5 years
- $1.36
- Implied price
- $24.44
- Return from $9.89
- 19.8% a year
To earn 15.0% a year on these assumptions you'd need to buy at $12.15 — today's price is already 18.6% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| -2.0% | 0.3% | 4.8% | 8.7% | 12.1% | 15.2% |
| 3.0% | 5.4% | 10.2% | 14.3% | 17.9% | 21.1% |
| 8.0% | 10.5% | 15.5% | 19.8% | 23.6% | 26.9% |
| 13.0% | 15.6% | 20.9% | 25.4% | 29.3% | 32.8% |
| 18.0% | 20.7% | 26.2% | 30.9% | 35.0% | 38.7% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
30-80.00%Social Signal Score
Mentions (6)
- Newsbusinesswire.com·18d ago·Negative
GMR Solutions Inc. Completes Term Loan Refinancing and $200 Million Debt Repayment LEWISVILLE, Texas--(BUSINESS WIRE)--GMR Solutions Inc. (“GMR”) (NYSE: GMRS), the nation's largest provider of emergency medical services, completed successful repricing of all its existing $2.9 billion Term Loan B facility due October 2032.RepricingGMR used approximately $200 million of cash on hand to repay outstanding term loan borrowings, reducing the outstanding principal amount of the facility to approximatel…
View source ↗ - Newsbusinesswire.com·24d ago·Negative
GMR Solutions Inc. Secures Commitments for Term Loan Repricing; Plans $200 Million Debt Paydown LEWISVILLE, Texas--(BUSINESS WIRE)--GMR Solutions Inc. (“GMR”) (NYSE: GMRS), the nation's largest provider of emergency medical services, announced that Global Medical Response, Inc., the borrower under its first lien term loan, has obtained binding commitments to complete a repricing of its existing $2.9 billion Term Loan B facility due October 2032. In connection with the transaction, GMR expects to…
View source ↗ - Newsmarketbeat.com·53d ago·Neutral
GMR Solutions Q2 Earnings Call Highlights GMR Solutions NYSE: GMRS reported second-quarter revenue growth and higher demand for its core emergency services, while adjusted EBITDA declined from the prior year as the company lapped favorable revenue estimate adjustments tied to older No Surprises Act claims and recorded IPO-related expenses.
View source ↗ - Newsseekingalpha.com·53d ago·Positive
GMR Solutions Inc. (GMRS) Q2 2026 Earnings Call Transcript GMR Solutions Inc. (GMRS) Q2 2026 Earnings Call Transcript
View source ↗ - Newszacks.com·54d ago·Neutral
GMR Solutions Inc. (GMRS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates While the top- and bottom-line numbers for GMR Solutions Inc. (GMRS) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
View source ↗ - Newsbusinesswire.com·54d ago·Neutral
GMR Solutions Inc. Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Reaffirms Full Year 2026 Guidance LEWISVILLE, Texas--(BUSINESS WIRE)--GMR Solutions Inc. (“GMR” or the “Company”) (NYSE: GMRS), the nation's largest provider of emergency medical services (“EMS”), today announced financial results for the three and six months ended June 30, 2026, and updated its full year 2026 financial guidance. “We are pleased with our second quarter results, which reflect operati
View source ↗
Earnings
Typical surprise -795.4% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 12$-1.84 vs $0.26miss
Estimates and results for GMRS via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by GMRS officers and directors.
- Bought
- $15k
- Sold
- $28.7m
1 trade
6 trades
- Van Horne Edwardsold
- Tierney Brian Scottsold
- Loporcaro Nicolasold
- Jacoba Lisasold
- Hall Jessicasold
- Cook Thomas A Asold
- Jacoba Lisabought
66 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in GMRS.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.